HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Wants To Inspire A Quitter Movement In The UK With Nicorette Campaign

Executive Summary

With its new marketing campaign for Nicorette, Johnson & Johnson wants to create a smoking cessation social movement using Facebook and a feature-packed website to help "quitters" stay away from cigarettes for good. 

You may also be interested in...



NRT Delivery Innovation Proposal In US Doesn't Deliver Expanded Indications

GSK's proposed usage for mouth spray product – reducing withdrawal symptoms, including nicotine craving – differs little from the first NRT product approved in US in 1984. Additional suggested label instructions primarily focus on stating NRTs can be used to reduce smoking or gradually stop tobacco use as opposed to quitting within a specified amount of time.

GSK Proposes Adding OTC Oral Spray To US Smoking Cessation Sector

FDA schedules Nonprescription Drugs Advisory Committee meeting 18 September to consider GSK's NDA for an OTC nicotine oral spray that delivers 1mg per spray.

Generational Split In British Attitudes To Digital Self-Care, PAGB Research Finds

A survey by the UK’s self-care industry association, PAGB, has found a marked difference in generational attitudes to digital health apps and devices in the UK, with two-thirds of 18 to 35 year olds in the country trusting such technology compared to only a quarter of 46 to 55 year olds.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel